Boiron (BATS-CHIXE:BOIP) - Stock Price, News & Analysis

BOIP Stock Overview

Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. More details

BOIP fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	2/6
Past Performance	1/6
Financial Health	6/6
Dividends	2/6

Rewards

Trading at 45.6% below our estimate of its fair value

Earnings are forecast to grow 7.58% per year

Risk Analysis

Shares are highly illiquid

Boiron SA Competitors

Animalcare Group

AIM:ANCR

UK£148.5m

Hikma Pharmaceuticals

LSE:HIK

UK£4.2b

ECO Animal Health Group

AIM:EAH

UK£44.7m

GSK

LSE:GSK

UK£53.4b

Price History & Performance

Summary of all time highs, changes and price drops for Boiron
Historical stock prices
Current Share Price	€50.60
52 Week High	€50.60
52 Week Low	€37.35
Beta	0.47
11 Month Change	0%
3 Month Change	n/a
1 Year Change	14.74%
33 Year Change	15.13%
5 Year Change	-11.23%
Change since IPO	20.68%

Recent updates

Shareholder Returns

	BOIP	GB Pharmaceuticals	GB Market
7D	0%	-2.3%	0.8%
1Y	14.7%	-2.7%	6.6%

Return vs Industry: BOIP exceeded the UK Pharmaceuticals industry which returned -7.1% over the past year.

Return vs Market: BOIP exceeded the UK Market which returned -2.4% over the past year.

Price Volatility

Is BOIP's price volatile compared to industry and market?
BOIP volatility
BOIP Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	6.6%
Market Average Movement	4.7%
10% most volatile stocks in GB Market	10.3%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: BOIP has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine BOIP's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1932	2,813	Valérie Lorentz-Poinsot	www.boiron.fr

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain.

Boiron SA Fundamentals Summary

How do Boiron's earnings and revenue compare to its market cap?
BOIP fundamental statistics
Market cap	€937.56m
Earnings (TTM)	€47.62m
Revenue (TTM)	€517.36m

19.6x

P/E Ratio

1.8x

P/S Ratio

Is BOIP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BOIP income statement (TTM)
Revenue	€517.36m
Cost of Revenue	€135.11m
Gross Profit	€382.25m
Other Expenses	€334.63m
Earnings	€47.62m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Mar 18, 2024

Earnings per share (EPS)	2.74
Gross Margin	73.88%
Net Profit Margin	9.20%
Debt/Equity Ratio	0.5%

How did BOIP perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

40%

Payout Ratio

Does BOIP pay a reliable dividends?

See BOIP dividend history and benchmarks

When do you need to buy BOIP by to receive an upcoming dividend?
Boiron dividend dates
Ex Dividend Date	Oct 18 2023
Dividend Pay Date	Oct 20 2023
Days until Ex dividend	401 days
Days until Dividend pay date	399 days